who should not use tirzepatide The hidden risks of GLP-1 weight loss prescriptions Tirzepatide (Zepbound) for the Treatment

Patients with Type 2 Diabetes and High Cholesterol Semaglutide is already approved for treating type 2 diabetes

It helps the skin retain moisture and improves its barrier function, which in turn enhances the skin's texture, giving it a smooth and even look

For the heart rate, at time points 0 and 10 min after administration there were no significant differences between the groups, while later on there were significant differences between Mel and Dex groups: patients receiving Dex by any route of administration had lower heart frequencies (after 10 and 60 min, p = 0.003

The first group had the lowest mean weight loss of 9.2% at 176 weeks